{"id":149376,"date":"2010-01-07T09:49:56","date_gmt":"2010-01-07T14:49:56","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=57520"},"modified":"2010-01-07T09:49:56","modified_gmt":"2010-01-07T14:49:56","slug":"zymogenetics-gets-79m-in-stock-sale","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/149376","title":{"rendered":"ZymoGenetics Gets $79M in Stock Sale"},"content":{"rendered":"\n
Biotech<\/a>, deals<\/a>, Finances<\/a><\/div>\n

\t\tLuke Timmerman wrote:<\/strong><\/p>\n

ZymoGenetics, the Seattle-based biotech company, said today<\/a> it has raised about $79 million after expenses from an underwritten stock offering. The company (NASDAQ: ZGEN<\/a>) sold 14 million shares at $6 apiece, and also offered its underwriters a 30-day option to buy another 2.1 million shares. Leerink Swann was the sole book-running manager of the offering, while Wedbush Morgan Securities, William Blair & Co., Canaccord Adams, and McAdams Wright Ragen served as co-managers. The price represents an 11 percent discount for investors from yesterday’s close of $6.77 a share. ZymoGenetics had about $103 million of cash and investments on hand as of the end of September, its most recent financial report.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Biotech, deals, Finances Luke Timmerman wrote: ZymoGenetics, the Seattle-based biotech company, said today it has raised about $79 million after expenses from an underwritten stock offering. The company (NASDAQ: ZGEN) sold 14 million shares at $6 apiece, and also offered its underwriters a 30-day option to buy another 2.1 million shares. Leerink Swann was the […]<\/p>\n","protected":false},"author":1192,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-149376","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/149376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1192"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=149376"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/149376\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=149376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=149376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=149376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}